دورية أكاديمية
أعرض في EDS

Blood C-peptide concentration as a proxy marker of cardiovascular disease: An observational cross-sectional study.

التفاصيل البيبلوغرافية
العنوان: Blood C-peptide concentration as a proxy marker of cardiovascular disease: An observational cross-sectional study.
المؤلفون: Adusu-Donkor L; Department of Chemical Pathology U.G.M.S, University of Ghana Accra Ghana.; Department of Chemical Pathology 37 Military Hospital Accra Ghana., Ofori EK; Department of Chemical Pathology U.G.M.S, University of Ghana Accra Ghana., Kotey FCN; Department of Medical Microbiology U.G.M.S, University of Ghana Accra Ghana.; FleRhoLife Research Consult Accra Ghana., Dogodzi FK; Department of Chemical Pathology U.G.M.S, University of Ghana Accra Ghana., Dziedzorm W; Department of Chemical Pathology U.G.M.S, University of Ghana Accra Ghana., Buabeng A; Department of Chemical Pathology U.G.M.S, University of Ghana Accra Ghana., Bernard SK; Department of Chemical Pathology U.G.M.S, University of Ghana Accra Ghana., Amponsah SK; Department of Medical Pharmacology U.G.M.S, University of Ghana Accra Ghana., Asare-Anane H; Department of Chemical Pathology U.G.M.S, University of Ghana Accra Ghana.
المصدر: Health science reports [Health Sci Rep] 2023 Sep 01; Vol. 6 (9), pp. e1535. Date of Electronic Publication: 2023 Sep 01 (Print Publication: 2023).
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: John Wiley and Sons, Inc Country of Publication: United States NLM ID: 101728855 Publication Model: eCollection Cited Medium: Internet ISSN: 2398-8835 (Electronic) Linking ISSN: 23988835 NLM ISO Abbreviation: Health Sci Rep Subsets: PubMed not MEDLINE
أسماء مطبوعة: Original Publication: [Hoboken, NJ] : John Wiley and Sons, Inc., [2017]-
مستخلص: Background and Aims: Cardiovascular diseases (CVDs) are among the leading causes of disability and early death in sub-Saharan Africa. Most of the current blood tests for CVD diagnosis involve performing about three test profiles; often at additional cost to patients. C-peptide, a cleavage product of proinsulin, is a promising marker that has the potential to serve as a proxy marker for diagnosing CVDs in resource-poor settings.
Methodology: The study was an observational cross-sectional one and involved 127 consenting persons diagnosed with CVD and 127 individuals without CVD. The socio-demographic and clinical characteristics of participants were obtained. Blood levels of C-peptide, fasting plasma glucose (FPG), total creatinine kinase (CK), creatine kinase myocardial bound (CKMB), lactate dehydrogenase (LDH), propeptide of brain natriuretic peptide (PBNP), Troponin T, lipids, and biomarkers of kidney and liver function were analyzed using ELISA and an automated analyzer. Insulin resistance was computed using the modified homeostatic model assessment (HOMA-IR).
Results: The CVD Group had significantly higher levels of C-peptide, CK, CKMB, troponin T, PBNP, FPG, HOMA-IR, and several selected kidney, liver, and lipid parameters compared to the non-CVD Group ( p  < 0.05 for all). Troponin T recorded a positive correlation ( r  = 0.34, p  < 0.001) with C-peptide among the CVD Group. The sensitivity and specificity of C-peptide in identifying CVD were 96.1% and 91.3% respectively (area under the curve = 0.938, p  < 0.001).
Conclusion: C-peptide levels were higher in the CVD Group and appeared to be a valuable (high sensitivity and specificity) biomarker in detecting CVD.
Competing Interests: The authors declare no conflicts of interest.
(© 2023 The Authors. Health Science Reports published by Wiley Periodicals LLC.)
References: Diabetes Metab Res Rev. 2020 Feb;36(2):e3210. (PMID: 31351021)
Crit Rev Clin Lab Sci. 2019 Jan;56(1):33-60. (PMID: 30457415)
J Intern Med. 2017 Jan;281(1):41-51. (PMID: 27640884)
Diabet Med. 2013 Jul;30(7):803-17. (PMID: 23413806)
Curr Pharm Des. 2019;25(38):4063-4084. (PMID: 31553287)
Postgrad Med. 2022 Apr;134(3):297-302. (PMID: 35142235)
BMC Cardiovasc Disord. 2021 Dec 28;21(1):620. (PMID: 34963447)
Clin Chem. 1972 Jun;18(6):499-502. (PMID: 4337382)
Mol Cells. 2003 Dec 31;16(3):323-30. (PMID: 14744022)
World J Gastroenterol. 2018 Aug 28;24(32):3663-3670. (PMID: 30166861)
Br J Pharmacol. 2013 Jun;169(3):493-511. (PMID: 23488589)
Cardiovasc Diabetol. 2022 Oct 3;21(1):201. (PMID: 36192784)
Lipids Health Dis. 2018 Nov 14;17(1):255. (PMID: 30428911)
Eur J Med Res. 2019 Feb 20;24(1):13. (PMID: 30782217)
Indian Heart J. 2018 Dec;70 Suppl 3:S105-S109. (PMID: 30595240)
Front Immunol. 2023 Apr 27;14:1176403. (PMID: 37180128)
J Diabetes Complications. 2013 Nov-Dec;27(6):538-47. (PMID: 23994433)
J Cell Physiol. 2019 Aug;234(10):16812-16823. (PMID: 30790284)
Sci Rep. 2018 Feb 28;8(1):3764. (PMID: 29491346)
Am J Cardiol. 1992 Sep 15;70(7):733-7. (PMID: 1519522)
Front Public Health. 2017 Nov 20;5:307. (PMID: 29209603)
Metab Syndr Relat Disord. 2016 May;14(4):210-6. (PMID: 26863426)
CNS Neurol Disord Drug Targets. 2011 Dec;10(8):921-7. (PMID: 22229322)
Diabetes Res Clin Pract. 2019 Apr;150:174-183. (PMID: 30878389)
J Cardiovasc Dev Dis. 2019 Apr 27;6(2):. (PMID: 31035613)
Diabetes Metab J. 2011 Feb;35(1):41-9. (PMID: 21537412)
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2004 Aug;29(4):419-23. (PMID: 16134594)
Pediatr Diabetes. 2007 Apr;8(2):53-9. (PMID: 17448127)
Lipids Health Dis. 2020 Mar 16;19(1):42. (PMID: 32178672)
Atherosclerosis. 2014 Sep;236(1):7-17. (PMID: 24998934)
Arterioscler Thromb Vasc Biol. 2013 May;33(5):1070-6. (PMID: 23430618)
Br J Pharmacol. 2012 Nov;167(6):1177-94. (PMID: 22725625)
BMC Public Health. 2021 Feb 25;21(1):401. (PMID: 33632204)
Curr Diab Rep. 2018 Jun 16;18(8):51. (PMID: 29909550)
Arch Gerontol Geriatr. 2017 Nov;73:263-268. (PMID: 28869884)
J Am Coll Cardiol. 2019 Nov 19;74(20):2529-2532. (PMID: 31727292)
Glob Heart. 2020 Feb 12;15(1):15. (PMID: 32489788)
Front Cardiovasc Med. 2021 Oct 01;8:713191. (PMID: 34660715)
Intern Emerg Med. 2016 Apr;11(3):299-305. (PMID: 27001886)
Future Cardiol. 2015 Sep;11(5):597-613. (PMID: 26491788)
Nat Rev Cardiol. 2020 May;17(5):259-260. (PMID: 32139904)
Mol Metab. 2020 Dec;42:101092. (PMID: 33010471)
Front Endocrinol (Lausanne). 2021 Aug 12;12:680501. (PMID: 34456859)
فهرسة مساهمة: Keywords: C‐peptide; cardiovascular disease; diabetes; inflammation; insulin resistance
تواريخ الأحداث: Date Created: 20230904 Latest Revision: 20230905
رمز التحديث: 20231215
مُعرف محوري في PubMed: PMC10472907
DOI: 10.1002/hsr2.1535
PMID: 37662537
قاعدة البيانات: MEDLINE
الوصف
تدمد:2398-8835
DOI:10.1002/hsr2.1535